Table 1. Number of admissions and age-standardised admission rate by Indigenous status, NSW, 2003/04 to 2007/08.
| Indigenous | Non-Indigenous | |||||||
| n | % | ASR | (95% CI) | n | % | ASR | (95% CI) | |
| Acute conditions | 15044 | 41.30% | 21.97 | (21.51–22.43) | 385300 | 40.50% | 11.4 | (11.37–11.44) |
| Appendicitis with generalised peritonitis | 153 | 0.40% | 0.17 | (0.14–0.20) | 4938 | 0.50% | 0.15 | (0.15–0.15) |
| Cellulitis | 1870 | 5.10% | 3.04 | (2.86–3.22) | 51459 | 5.40% | 1.48 | (1.47–1.49) |
| Convulsions and epilepsy | 3777 | 10.40% | 5.57 | (5.36–5.78) | 51346 | 5.40% | 1.56 | (1.55–1.58) |
| Dental conditions | 2545 | 7.00% | 2.58 | (2.46–2.69) | 67049 | 7.00% | 2.06 | (2.05–2.08) |
| Ear Nose and Throat conditions | 2933 | 8.10% | 2.84 | (2.71–2.97) | 50118 | 5.30% | 1.56 | (1.55–1.58) |
| Gangrene | 116 | 0.30% | 0.29 | (0.23–0.36) | 5067 | 0.50% | 0.14 | (0.14–0.15) |
| Dehydration and gastroenteritis | 1281 | 3.50% | 2.59 | (2.41–2.77) | 69784 | 7.30% | 2.01 | (2.00–2.03) |
| Pelvic inflammatory disease | 284 | 0.80% | 0.39 | (0.35–0.44) | 7489 | 0.80% | 0.46 | (0.45–0.47) |
| Perforated/bleeding ulcers | 158 | 0.40% | 0.4 | (0.33–0.48) | 8037 | 0.80% | 0.22 | (0.22–0.23) |
| Pyelonephritis | 1930 | 5.30% | 4.12 | (3.87–4.37) | 70191 | 7.40% | 1.99 | (1.98–2.00) |
| Chronic conditions | 20688 | 56.80% | 53.5 | (52.65–54.36) | 546973 | 57.50% | 15.38 | (15.34–15.42) |
| Angina | 2018 | 5.50% | 5.49 | (5.22–5.77) | 97683 | 10.30% | 2.73 | (2.71–2.74) |
| Asthma | 3062 | 8.40% | 3.77 | (3.60–3.93) | 60097 | 6.30% | 1.87 | (1.85–1.88) |
| Congestive cardiac failure | 1078 | 3.00% | 4.01 | (3.73–4.30) | 67257 | 7.10% | 1.81 | (1.79–1.82) |
| COPD | 3125 | 8.60% | 10.65 | (10.23–11.08) | 91535 | 9.60% | 2.52 | (2.50–2.54) |
| Diabetes complications | 11824 | 32.50% | 31.5 | (30.86–32.14) | 228072 | 24.00% | 6.38 | (6.35–6.40) |
| Hypertension | 318 | 0.90% | 0.79 | (0.69–0.90) | 10554 | 1.10% | 0.29 | (0.29–0.30) |
| Iron deficiency anaemia | 455 | 1.20% | 1.24 | (1.11–1.38) | 30461 | 3.20% | 0.86 | (0.85–0.87) |
| Nutritional deficiencies | 5 | 0.00% | 0.01 | (0.00–0.01) | 192 | 0.00% | 0.01 | (0.00–0.01) |
| Rheumatic heart disease | 124 | 0.30% | 0.2 | (0.16–0.25) | 2851 | 0.30% | 0.08 | (0.08–0.08) |
| Vaccine preventable conditions | 882 | 2.40% | 1.51 | (1.39–1.65) | 23040 | 2.40% | 0.67 | (0.66–0.68) |
| Influenza and pneumonia | 682 | 1.90% | 1.22 | (1.10–1.34) | 18429 | 1.90% | 0.53 | (0.53–0.54) |
| Other vaccine-preventable | 201 | 0.60% | 0.3 | (0.26–0.35) | 4635 | 0.50% | 0.14 | (0.13–0.14) |
| Overall | 36430 | 100% | 76.48 | (75.51–77.46) | 951174 | 100% | 27.34 | (27.29–27.40) |
Note: ASR, age standardised rate per 1000 population; CI, confidence interval. With the exception of pelvic inflammatory disease and nutritional deficiencies, all rates were statistically significantly higher for Indigenous Australians (p<0.05).